License Exercise and Grant Sample Clauses

License Exercise and Grant. Subject to the provisions of Section 3.5 below, ARIAD may exercise the Therapeutic Option with respect to any Designated Gene Product which is subject to a Therapeutic Option solely by giving Incyte express written notice of exercise, specifying such Designated Gene
Sample 1
AutoNDA by SimpleDocs
License Exercise and Grant. Subject to the provisions of Section 3.5 below, ARIAD may exercise the Antisense Option with respect to any Designated Gene Product which is subject to a Antisense Option solely by giving Incyte express written notice of exercise, specifying such Designated Gene Product to which the license shall apply, and by paying to Incyte a license fee of [*]prior to the expiration of the applicable option period. Upon Incyte's timely receipt of written notice of ARIAD's exercise and payment of the applicable license fee with respect to such Designated Gene Product, and subject to the provisions of Section 4.5 below, Incyte grants to ARIAD a perpetual, worldwide exclusive license (with a right to sublicense as provided in Section 3.6) under the Incyte Patent Rights directed to such Designated Gene Product to discover, develop, make, have made, use and sell Antisense Product(s) in the Antisense Field of Use.
Sample 1
License Exercise and Grant. Subject to the provisions of Section 3.5, diaDexus may exercise the Therapeutic Option with respect to any Designated Gene Product which is subject to a Therapeutic Option solely by giving Incyte express notice of exercise, specifying such Designated Gene Product to which the license shall apply, and by paying to Incyte a license fee of ****** prior to the expiration of the applicable option period. Upon Incyte's timely receipt of notice of diaDexus' exercise and payment of the applicable license fee with respect to such Designated Gene Product, and subject to the provisions of Section 3.5, Incyte thereby grant to diaDexus a perpetual, world-wide, exclusive license, with a right to sublicense, under the Incyte Patent Rights covering such Designated Gene Product or the use of such Designated Gene Product to discover, develop, make, have made, use, offer to sell, sell, import, export and distribute such Designated Gene Product as a Therapeutic Protein Product(s) in the Therapeutic Field of Use. Any such sublicense shall be in writing and shall impose obligations on the sublicense that are consistent with those applicable to diaDexus under this Agreement. The grant and term of such license is subject to Section 7.2.
Sample 1
License Exercise and Grant. Subject to the provisions of Section 3.5, ***** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Sample 1

Related to License Exercise and Grant

  • Right to Exercise; Exercise Price The Holder shall have the right to exercise this Warrant at any time and from time to time during the period beginning on the Issue Date and ending on the Expiration Date as to all or any part of the shares of Common Stock covered hereby (the “Warrant Shares”). The “Exercise Price” for each Warrant Share purchased by the Holder upon the exercise of this Warrant shall be $2.50, subject to adjustment for the events specified in Section 6 below.

  • Initial Exercise Price; Exercise of Rights; Detachment of Rights (a) Subject to adjustment as herein set forth, each Right will entitle the holder thereof, after the Separation Time, to purchase, for the Exercise Price, or its U.S. Dollar Equivalent as at the Business Day immediately preceding the day of exercise of the Right, one Common Share. Notwithstanding any other provision of this Agreement, any Rights held by the Corporation or any of its Subsidiaries shall be void.

  • Cumulative Exercisability To the extent that the Option is vested and exercisable, the Grantee has the right to exercise the Option (to the extent not previously exercised), and such right shall continue, until the expiration or earlier termination of the Option.

  • Right to Exercise Option 3.1 The right to exercise the Option shall terminate forthwith upon the Employee ceasing to be an employee of a Group Company except in the following cases:

  • No Rights as Stockholder Until Exercise This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.

  • Partial Exercise; Effective Date of Exercise In case of any partial exercise of this Warrant, the Company shall cancel this Warrant upon surrender hereof and shall execute and deliver a new Warrant of like tenor and date for the balance of the shares of Common Stock purchasable hereunder. This Warrant shall be deemed to have been exercised immediately prior to the close of business on the date of its surrender for exercise as provided above. The person entitled to receive the shares of Common Stock issuable upon exercise of this Warrant shall be treated for all purposes as the holder of record of such shares as of the close of business on the date the Company receives the Notice of Exercise, subject to receipt of the Exercise Amount.

  • No Rights as Shareholder Until Exercise This Warrant does not entitle the Holder to any voting rights or other rights as a shareholder of the Company prior to the exercise hereof. Upon the surrender of this Warrant and the payment of the aggregate Exercise Price (or by means of a cashless exercise), the Warrant Shares so purchased shall be and be deemed to be issued to such Holder as the record owner of such shares as of the close of business on the later of the date of such surrender or payment.

  • Notice of Exercise of Option This Option may be exercised by the ---------------------------- Optionee, or by the Optionee's administrators, executors or personal representatives, by a written notice (in substantially the form of the Notice of Exercise attached hereto as Schedule B) signed by the Optionee, or by such administrators, executors or personal representatives, and delivered or mailed to the Company as specified in Section 14 hereof to the attention of the President or such other officer as the Company may designate. Any such notice shall (a) specify the number of shares of Stock which the Optionee or the Optionee's administrators, executors or personal representatives, as the case may be, then elects to purchase hereunder, (b) contain such information as may be reasonably required pursuant to Section 12 hereof, and (c) be accompanied by (i) a certified or cashier's check payable to the Company in payment of the total Exercise Price applicable to such shares as provided herein, (ii) shares of Stock owned by the Optionee and duly endorsed or accompanied by stock transfer powers having a Fair Market Value equal to the total Exercise Price applicable to such shares purchased hereunder, or (iii) a certified or cashier's check accompanied by the number of shares of Stock whose Fair Market Value when added to the amount of the check equals the total Exercise Price applicable to such shares purchased hereunder. Upon receipt of any such notice and accompanying payment, and subject to the terms hereof, the Company agrees to issue to the Optionee or the Optionee's administrators, executors or personal representatives, as the case may be, stock certificates for the number of shares specified in such notice registered in the name of the person exercising this Option.

  • Conditional Exercise Notwithstanding any other provision hereof, if an exercise of any portion of this Warrant is to be made in connection with a public offering or a sale of the Company (pursuant to a merger, sale of stock, or otherwise), such exercise may at the election of the Holder be conditioned upon the consummation of such transaction, in which case such exercise shall not be deemed to be effective until immediately prior to the consummation of such transaction.

  • Commencement of Exercisability (a) Subject to Sections 3.1(b), 3.1(c) and 3.3, the Option shall become vested and exercisable in such amounts and at such times as are set forth in the Grant Notice.

Time is Money Join Law Insider Premium to draft better contracts faster.